SOA
CLDI.WS

Sea Otter Advisors’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Sea Otter Advisors’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– – – 47
2024
Q1 		– Sell
-4,871
Closed -$244 – 181
2023
Q4 		$244 Hold
4,871
– – ﹤0.01% 190
2023
Q3 		$1.07K Buy
+4,871
New +$891 ﹤0.01% 239

Other funds holding CLDI.WS

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Sea Otter Advisors's CLDI.WS Position: Q2 2024 in Review

Sea Otter Advisors held its Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) position steady in Q2 2024 at 0 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #47.

Sea Otter Advisors first reported a position in CLDI.WS in Q3 2023 and has held it in 2 quarters since. The position peaked at $1.07K in Q3 2023. 15 funds tracked by Wall St. Rank hold CLDI.WS as of Q2 2024.

  • Sea Otter Advisors held 0 shares of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 worth $205 as of Q2 2024.
  • Sea Otter Advisors left its Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 share count unchanged in Q2 2024.
  • Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 made up ﹤0.01% of Sea Otter Advisors's portfolio in Q2 2024, its #47 holding.
  • Sea Otter Advisors first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q3 2023 and has held it in 2 quarters since.
  • Sea Otter Advisors's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $1.07K in Q3 2023.
  • 15 funds tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q2 2024.

Based on Sea Otter Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.